vs
Side-by-side financial comparison of Webull Corp (BULL) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $131.5M, roughly 1.6× Webull Corp). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs -21.5%, a 78.9% gap on every dollar of revenue. Webull Corp produced more free cash flow last quarter ($271.7M vs $142.2M).
Webull Corporation, often stylized as simply Webull, is a US-based financial services holding company headquartered in St. Petersburg, Florida. It provides an electronic trading platform of the same name.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
BULL vs IDYA — Head-to-Head
Income Statement — Q2 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $131.5M | $207.8M |
| Net Profit | $-28.3M | $119.2M |
| Gross Margin | — | — |
| Operating Margin | -16.3% | 52.2% |
| Net Margin | -21.5% | 57.4% |
| Revenue YoY | 46.3% | — |
| Net Profit YoY | -144.3% | 330.1% |
| EPS (diluted) | — | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $207.8M | ||
| Q2 25 | $131.5M | — | ||
| Q3 24 | — | $0 | ||
| Q2 24 | $89.9M | $0 | ||
| Q1 24 | — | $0 | ||
| Q3 22 | — | $29.7M |
| Q3 25 | — | $119.2M | ||
| Q2 25 | $-28.3M | — | ||
| Q3 24 | — | $-51.8M | ||
| Q2 24 | $-11.6M | $-52.8M | ||
| Q1 24 | — | $-39.6M | ||
| Q3 22 | — | $1.6M |
| Q3 25 | — | 52.2% | ||
| Q2 25 | -16.3% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -11.4% | — | ||
| Q1 24 | — | — | ||
| Q3 22 | — | 2.2% |
| Q3 25 | — | 57.4% | ||
| Q2 25 | -21.5% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -12.9% | — | ||
| Q1 24 | — | — | ||
| Q3 22 | — | 5.4% |
| Q3 25 | — | $1.33 | ||
| Q2 25 | — | — | ||
| Q3 24 | — | $-0.60 | ||
| Q2 24 | — | $-0.68 | ||
| Q1 24 | — | $-0.53 | ||
| Q3 22 | — | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $476.7M | $786.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $751.6M | $1.1B |
| Total Assets | $2.6B | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $786.9M | ||
| Q2 25 | $476.7M | — | ||
| Q3 24 | — | $920.0M | ||
| Q2 24 | — | $701.7M | ||
| Q1 24 | — | $698.8M | ||
| Q3 22 | — | $386.2M |
| Q3 25 | — | $1.1B | ||
| Q2 25 | $751.6M | — | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | $-2.9B | $931.7M | ||
| Q1 24 | — | $935.3M | ||
| Q3 22 | — | $368.8M |
| Q3 25 | — | $1.2B | ||
| Q2 25 | $2.6B | — | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $973.7M | ||
| Q1 24 | — | $961.5M | ||
| Q3 22 | — | $410.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $272.1M | $142.2M |
| Free Cash FlowOCF − Capex | $271.7M | $142.2M |
| FCF MarginFCF / Revenue | 206.6% | 68.4% |
| Capex IntensityCapex / Revenue | 0.3% | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $142.2M | ||
| Q2 25 | $272.1M | — | ||
| Q3 24 | — | $-49.2M | ||
| Q2 24 | — | $-32.9M | ||
| Q1 24 | — | $-43.8M | ||
| Q3 22 | — | $-24.2M |
| Q3 25 | — | $142.2M | ||
| Q2 25 | $271.7M | — | ||
| Q3 24 | — | $-49.7M | ||
| Q2 24 | — | $-33.9M | ||
| Q1 24 | — | $-45.1M | ||
| Q3 22 | — | $-25.3M |
| Q3 25 | — | 68.4% | ||
| Q2 25 | 206.6% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 22 | — | -85.1% |
| Q3 25 | — | 0.0% | ||
| Q2 25 | 0.3% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 22 | — | 3.7% |
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 22 | — | -14.96× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
